SA
Shenzhen Alvantis Pharma Co., Ltd.
Manufacturer · Shenzhen, China
Overview
Shenzhen Alvantis Pharma was founded in 2020 and focuses on GLP-1 receptor agonist peptides. It runs an R&D centre in Shenzhen and a production centre in Zhongshan, Guangdong, rated at about 50 kg of peptide per year, and sells GMP-grade peptide APIs from gram to kilogram scale, sterile peptides in vials, research-use peptides and peptide reference materials such as tirzepatide and semaglutide. The FDA DMF list shows an active Type II DMF for tirzepatide. No regulator inspection is cited on its site.
Capabilities
- Tirzepatide and semaglutide API
- Sterile peptide API in vials
- Peptide reference materials
- Custom peptide synthesis
Quality signals
| GMP evidence | Not found |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |